Spots Global Cancer Trial Database for Early Detection of Cardiac Damage With CMR in Women With Breast Cancer
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Early Detection of Cardiac Damage With CMR in Women With Breast Cancer
Official Title: Early Detection of Cardiac Damage With CMR in Women With Breast Cancer
Study ID: NCT04046315
Interventions
Study Description
Brief Summary: With this study the investigators will assess early cardiac damage by means of Global Longitudinal Strain (GLS) in newly diagnosed breast cancer (BC) patients treated with anthracycline-based chemotherapy, and to investigate whether myocardial damage as measured with T1 / T2 Cardiovascular Magnetic Resonance (CMR) mapping and plasma hs-Troponin T is related to changes in GLS.
Detailed Description:
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: FEMALE
Healthy Volunteers: No
Locations
Radboud University Medical Center, Nijmegen, , Netherlands
Contact Details
Name: Saloua El Messaoudi, PhD
Affiliation: Radboud University Medical Center
Role: STUDY_CHAIR
Name: Angela Maas, PhD
Affiliation: Radboud University Medical Center
Role: PRINCIPAL_INVESTIGATOR
Name: Robin Nijveldt, PhD
Affiliation: Radboud University Medical Center
Role: STUDY_CHAIR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
